New: Introducing the Finviz Crypto Map

Learn More
Last Close
Jul 25 04:00PM ET
14.50
Dollar change
+0.05
Percentage change
0.35
%
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-
Enterprise Value- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-
Income- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y-
Sales- P/B- EPS next Y- ROA- Short Interest- Perf YTD0.00%
Book/sh- P/C- EPS next 5Y- ROE- 52W High15.19 -4.57% Perf Year-
Cash/sh- P/FCF- EPS past 3/5Y- - ROIC- 52W Low14.00 3.57% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility- - Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM- Oper. Margin- ATR (14)0.78 Perf 10Y-
Dividend Ex-Date- Quick Ratio- Sales Y/Y TTM- Profit Margin- RSI (14)- Recom-
Dividend Gr. 3/5Y- - Current Ratio- EPS Q/Q- SMA200.12% Beta- Target Price-
Payout- Debt/Eq- Sales Q/Q- SMA500.12% Rel Volume0.26 Prev Close14.45
Employees89 LT Debt/Eq- Earnings- SMA2000.12% Avg Volume1.81M Price14.50
IPOJul 23, 2025 Option/ShortNo / No EPS/Sales Surpr.- - Trades Volume462,159 Change0.35%
Carlsmed, Inc. engages in the development of AI based technology solutions to the medical industry. Its solutions are utilized as an information database for surgeons using traditional surgical techniques. The company was founded by Mike Cordonnier and Niall Casey and is headquartered in Carlsbad, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
B CAPITAL GROUP MANAGEMENT, L.10% OwnerJul 24 '25Buy15.001,333,33319,999,9955,013,839Jul 24 08:51 PM
Sidow KevinDirectorJul 24 '25Buy15.0013,333199,99559,566Jul 24 08:32 PM
Mittendorff Robert IIDirectorJul 24 '25Buy15.001,333,33319,999,9955,013,839Jul 24 08:31 PM
ROOT JONATHAN DDirectorJul 24 '25Buy15.00466,6666,999,990483,999Jul 24 08:27 PM
YOUNG PHILIP MDirectorJul 24 '25Buy15.0059,999899,98553,333Jul 24 08:25 PM